Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
McKesson
US Department of Justice
Deloitte
Express Scripts
Healthtrust
Medtronic
Julphar

Generated: December 14, 2018

DrugPatentWatch Database Preview

Promius Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for PROMIUS PHARMA, and what generic alternatives to PROMIUS PHARMA drugs are available?

PROMIUS PHARMA has four approved drugs.

There are six US patents protecting PROMIUS PHARMA drugs.

There are six patent family members on PROMIUS PHARMA drugs in five countries.

Summary for Promius Pharma
International Patents:6
US Patents:6
Tradenames:4
Ingredients:4
NDAs:4
Patent Litigation for Promius Pharma: See patent lawsuits for Promius Pharma

Drugs and US Patents for Promius Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,439,911 ➤ Sign Up Y ➤ Sign Up
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Promius Pharma ISMO isosorbide mononitrate TABLET;ORAL 019091-001 Dec 30, 1991 DISCN No No ➤ Sign Up ➤ Sign Up
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-001 Oct 27, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,775,851 ➤ Sign Up Y ➤ Sign Up
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,877,974 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Promius Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-003 Nov 7, 1988 3,632,645 ➤ Sign Up
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-001 Dec 28, 1984 3,726,919 ➤ Sign Up
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-002 Nov 7, 1988 3,632,645 ➤ Sign Up
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-003 Dec 28, 1984 3,857,952 ➤ Sign Up
Promius Pharma TENEX guanfacine hydrochloride TABLET;ORAL 019032-001 Oct 27, 1986 3,632,645 ➤ Sign Up
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-003 Dec 28, 1984 3,726,919 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for PROMIUS PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.05% ➤ Subscribe 2018-02-15
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Deloitte
Queensland Health
Teva
UBS
Farmers Insurance
Julphar
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.